Oramed Pharmaceuticals (ORMP) Cash from Operations Growth (1y) (2011 - 2026)
Oramed Pharmaceuticals (ORMP) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
17.16% |
| Date | Value |
|---|
| Mar 31, 2026 |
17.16% |
| Dec 31, 2025 |
75.61% |
| Sep 30, 2025 |
77.12% |
| Jun 30, 2025 |
-270.28% |
| Mar 31, 2025 |
-138.41% |
| Dec 31, 2024 |
-34.77% |
| Sep 30, 2024 |
-923.20% |
| Jun 30, 2024 |
178.82% |
| Mar 31, 2024 |
73.40% |
| Dec 31, 2023 |
82.41% |
| Sep 30, 2023 |
69.03% |
| Jun 30, 2023 |
68.98% |
| Mar 31, 2023 |
39.19% |
| Nov 30, 2021 |
-12.21% |
| May 31, 2021 |
-67.95% |
| Feb 28, 2021 |
10.47% |
| Nov 30, 2020 |
-105.34% |
| May 31, 2020 |
8.20% |
| Feb 29, 2020 |
-92.62% |
| Nov 30, 2019 |
27.48% |
